This topic contains a solution. Click here to go to the answer

Author Question: In order for a study to qualify for an expedited IRB review, the researcher must demonstrate that ... (Read 18 times)

Arii_bell

  • Hero Member
  • *****
  • Posts: 596
In order for a study to qualify for an expedited IRB review, the researcher must demonstrate that
 
  a. subjects will be paid for their participation.
  b. the study is being carried out in a standard psychological research laboratory.
  c. the study will present no more than minimal risk of harm to the subjects.
  d. the results of the study will be published in a prestigious scientific journal.

Question 2

In order for a study to qualify for an exemption from IRB review, the study must ensure that,
 
  1) if a subject's privacy is violated, the disclosure would not result in legal difficulties, impaired financial or employment status, or marred reputation for that participant; and 2)
 
   a. the data must by anonymous.
   b. the subjects are paid for their participation.
   c. only enrolled college students are being used in the study.
   d. only students majoring in psychology, or other scientific disciplines, are participating.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jamesnevil303

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

c

Answer to Question 2

a




Arii_bell

  • Member
  • Posts: 596
Reply 2 on: Jun 20, 2018
Wow, this really help


chjcharjto14

  • Member
  • Posts: 342
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

In 1844, Charles Goodyear obtained the first patent for a rubber condom.

Did you know?

Egg cells are about the size of a grain of sand. They are formed inside of a female's ovaries before she is even born.

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library